Initial Management of Atrial Flutter with Rapid Ventricular Response
Immediate Assessment and Management
- For hemodynamically unstable patients with atrial flutter and rapid ventricular response causing myocardial ischemia, hypotension, or heart failure, the American College of Cardiology recommends immediate synchronized direct-current cardioversion 1, 2, 3
- For hemodynamically stable patients, initial management focuses on ventricular rate control, as recommended by the American College of Cardiology 1, 4
Pharmacological Rate Control Options
- The American Heart Association recommends beta blockers, such as metoprolol tartrate, as a first-line agent for rate control in hemodynamically stable patients 1, 2
- The American College of Cardiology suggests nondihydropyridine calcium channel blockers, such as diltiazem, as an alternative first-line agent for rate control in hemodynamically stable patients 1, 2
- Digoxin may be used as an adjunct to beta blockers or calcium channel blockers for rate control, as recommended by the American College of Cardiology 4
Important Considerations and Contraindications
- The American College of Cardiology advises avoiding nondihydropyridine calcium channel antagonists in patients with decompensated heart failure 1, 4
- Beta blockers are preferred in patients with systolic heart failure due to their favorable effect on morbidity and mortality, according to the American College of Cardiology 4, 5
Cardioversion Considerations
- The American Heart Association recommends considering electrical cardioversion when rapid ventricular response does not respond promptly to pharmacological therapies 1, 3
- Anticoagulation should be initiated as soon as possible and continued for at least 4 weeks after cardioversion, unless contraindicated, as recommended by the American College of Cardiology 1, 2
Transition to Oral Therapy
- After achieving rate control with IV medications, the American College of Cardiology recommends transitioning to oral agents, such as beta blockers or calcium channel blockers 1, 2
- Combination therapy with digoxin and a beta blocker or calcium channel antagonist may be considered for optimal rate control, as suggested by the American College of Cardiology 4, 6